Coronary restenosis after sirolimus-eluting stent implantation: morphological description and mechanistic analysis from a consecutive series of cases
- PMID: 12860901
- DOI: 10.1161/01.CIR.0000083366.33686.11
Coronary restenosis after sirolimus-eluting stent implantation: morphological description and mechanistic analysis from a consecutive series of cases
Abstract
Background: We describe the clinical and morphological patterns of restenosis after sirolimus-eluting stent (SES) implantation.
Methods and results: From 121 patients with coronary angiography obtained >30 days after SES implantation, restenosis (diameter stenosis >50%) was identified in 19 patients and 20 lesions (located at the proximal 5-mm segment in 30% or within the stent in 70%). Residual dissection after the procedure or balloon trauma outside the stent was identified in 83% of the proximal edge lesions. Lesions within the stent were focal, and stent discontinuity was identified in some lesions evaluated by intravascular ultrasound.
Conclusions: Sirolimus-eluting stent edge restenosis is frequently associated with local trauma outside the stent. In-stent restenosis occurs as a localized lesion, commonly associated with a discontinuity in stent coverage. Local conditions instead of intrinsic drug-resistance to sirolimus are likely to play a major role in post-SES restenosis.
Comment in
-
Restenosis: the mouse that roared.Circulation. 2003 Jul 22;108(3):248-9. doi: 10.1161/01.CIR.0000082927.86409.8D. Circulation. 2003. PMID: 12876132 No abstract available.
-
Drug-eluting stent restenosis rates?Circulation. 2004 Mar 9;109(9):e154. doi: 10.1161/01.CIR.0000118319.12607.EA. Circulation. 2004. PMID: 15007023 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
